Market Introduction
APAC is one of the fastest growing market for molecular biology enzymes, kits & reagents market. China, India and Japan are three major contributors to the growth of the market which is driven by increasing investments by the governments of the respective countries in the region. The rise in the development and research for the genomics and the rise in the programs for the genomics are expected to drive the molecular biology enzymes, kits & reagents market in the forecast period. In addition, the initiatives by the government of India for the startups in biotechnology sectors are likely to foster the growth of the molecular biology enzymes, kits & reagents market in the country.
The COVID-19 pandemic started in China, and it has affected various Asian countries such as India, South Korea, Australia, Malaysia, and Singapore. Countries in APAC are facing challenges due to the increasing incidence of COVID-19. Currently, India is the second worse hit country worldwide. Many measures have been implemented to contain the spread of COVID-19, resulting in significant operational disruption for many companies, including the healthcare industry. Staff quarantine, supply-chain failures, and reductions in demand have generated serious complications for companies. Rising prevalence of COVID-19 and increasing product launches of PCR tests for detection of COVID-19 are anticipated to support the market's growth during the forecast period. In April 2021, Fujita Health University in Toyoake started using a fully automated COVID-19 testing system from Kawasaki Heavy Industries Ltd. The machine conducts a polymerase chain reaction (PCR) test to reduce the risk of infection for technicians. Therefore, the COVID-19 pandemic is estimated to positively impact the molecular biology enzymes, kits & reagents market.
Market Overview and Dynamics
The molecular biology enzymes, kits, and reagents market in APAC is expected to grow from US$ 2,445.67 million in 2021 to US$ 7,809.89 million by 2028; it is estimated to grow at a CAGR of 18.0% from 2021 to 2028. The growth of APAC molecular biology enzymes, kits & reagents market is prominently attributed to the increasing investments for life science projects, focus on adoption and expansion of personalized medicines, and implementation of strategic sales strategies of market players in the region. In April 2020, MedGenome announced its plan to expand its infrastructure in South Asia. The company invested around US$ 55.0 Mn which will increase the access of genomic studies and research for considerable population in South Asia. In addition, the organizations in the region are also focusing on promoting educational and awareness programs for molecular biology, which is further expected to offer lucrative opportunity for market growth. For instance, in September 2019, Organization for Women in Science for the Developing World announced a regional workshop to discuss recent trends and opportunities in the field of molecular biology. In addition, in April 2021, the Thailand Board of Investment approved new biotechnology products to meet the demand of healthcare in the country. The cost of four new project is around US$ 78.0 million. Such developments are projected to have constructive impact on the market growth.
Key Market Segments
APAC molecular biology enzymes, kits, and reagents market is segmented into product, application, end user, and country. Based on product, the molecular biology enzymes, kits, and reagents market is bifurcated into enzymes and kits & reagents. The market, by enzymes, is further segmented into polymerases, ligases, reverse transcriptases, phosphatases, proteases and proteinases, restriction endonuclease, and other. The kits & reagent segment held a larger market share in 2020. The molecular biology enzymes, kits, and reagents market, based on application, is segmented into epigenetics, sequencing, synthetic biology, polymerase chain reaction, and other. In 2020, the sequencing segment held the largest market share. In terms of end user, the molecular biology enzymes, kits, and reagents market is segmented into biotechnological and pharmaceutical companies, hospitals and diagnostic centers, and academic and research institutes. The biotechnological and pharmaceutical companies segment held the largest share of the market in 2020. Based on country, the APAC molecular biology enzymes, kits, and reagents market is segmented into Australia, China, India, Japan, South Korea, and rest of Europe. China held the largest market share in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the molecular biology enzymes, kits, and reagents market in APAC are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Agilent Technologies, Inc.; F. HOFFMANN-LA ROCHE LTD; Illumina, Inc.; Merck KGAA; MERIDIAN BIOSCIENCE, INC; Promega Corporation; Qiagen; and THERMO FISHER SCIENTIFIC INC.
Reasons to buy report
- To understand the APAC molecular biology enzymes, kits, and reagents market landscape and identify market segments that are most likely to guarantee a strong return.
- Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC molecular biology enzymes, kits, and reagents market.
- Efficiently plan M&A and partnership deals in APAC molecular biology enzymes, kits, and reagents market by identifying market segments with the most promising probable sales.
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC molecular biology enzymes, kits, and reagents market.
- Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.
APAC Molecular Biology Enzymes, Kits, and Reagents Market Segmentation
APAC Molecular Biology Enzymes, Kits, and Reagents Market - By Product
- Enzymes
- Polymerases
- Ligases
- Reverse Transcriptases
- Phosphatases
- Proteases and Proteinases
- Restriction Endonuclease
- Other
- Kits and Reagents
APAC Molecular Biology Enzymes, Kits, and Reagents Market - By Application
- Epigenetics
- Sequencing
- Synthetic Biology
- Polymerase Chain Reaction
- Other
APAC Molecular Biology Enzymes, Kits, and Reagents Market - By End User
- Biotechnological and Pharmaceutical Companies
- Hospitals and Diagnostic Centres
- Academic and Research Institutes
APAC Molecular Biology Enzymes, Kits, and Reagents Market - By Country
- Australia
- China
- India
- Japan
- South Korea
- Rest of APAC
APAC Molecular Biology Enzymes, Kits, and Reagents Market - Company Profiles
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- THERMO FISHER SCIENTIFIC INC
Asia Pacific Molecular Biology Enzymes, Kits, and Reagents Market Strategic Insights
Asia Pacific Molecular Biology Enzymes, Kits, and ReagentsMarket Report Highlights
| Report Attribute | Details |
| Market size in 2021 | US$ 2,445.67 Million |
| Market Size by 2028 | US$ 7,809.89 Million |
| CAGR (2021 - 2028) | 18.0% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| Asia-Pacific | China, India, Japan, Australia, Rest of Asia-Pacific |
| Market leaders and key company profiles |
|
Asia Pacific Molecular Biology Enzymes, Kits, and Reagents Market Country and Regional Insights
